226 related articles for article (PubMed ID: 21595512)
1. Neuropeptide y and neuropeptide y y5 receptor interaction restores impaired growth potential of aging bone marrow stromal cells.
Igura K; Haider HKh; Ahmed RP; Sheriff S; Ashraf M
Rejuvenation Res; 2011 Aug; 14(4):393-403. PubMed ID: 21595512
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line.
Sheriff S; Ali M; Yahya A; Haider KH; Balasubramaniam A; Amlal H
Mol Cancer Res; 2010 Apr; 8(4):604-14. PubMed ID: 20332211
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis.
Medeiros PJ; Jackson DN
Peptides; 2013 Oct; 48():106-13. PubMed ID: 23932937
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y receptor interactions regulate its mitogenic activity.
Czarnecka M; Lu C; Pons J; Maheswaran I; Ciborowski P; Zhang L; Cheema A; Kitlinska J
Neuropeptides; 2019 Feb; 73():11-24. PubMed ID: 30503694
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of neuropeptide Y, Y1 and Y2 receptors, but not Y5 receptor, within hippocampus and temporal lobe cortex of tremor rats.
Xu X; Guo F; He Q; Cai X; Min D; Wang Q; Wang S; Tian L; Cai J; Zhao Y
Neuropeptides; 2014 Apr; 48(2):97-105. PubMed ID: 24444822
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y stimulates proliferation and migration in the 4T1 breast cancer cell line.
Medeiros PJ; Al-Khazraji BK; Novielli NM; Postovit LM; Chambers AF; Jackson DN
Int J Cancer; 2012 Jul; 131(2):276-86. PubMed ID: 21823118
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y enhances proliferation and prevents apoptosis in rat bone marrow stromal cells in association with activation of the Wnt/β-catenin pathway in vitro.
Wu J; Liu S; Meng H; Qu T; Fu S; Wang Z; Yang J; Jin D; Yu B
Stem Cell Res; 2017 May; 21():74-84. PubMed ID: 28411439
[TBL] [Abstract][Full Text] [Related]
8. Y5 receptors mediate neuropeptide Y actions at excitatory synapses in area CA3 of the mouse hippocampus.
Guo H; Castro PA; Palmiter RD; Baraban SC
J Neurophysiol; 2002 Jan; 87(1):558-66. PubMed ID: 11784771
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy.
Lu C; Everhart L; Tilan J; Kuo L; Sun CC; Munivenkatappa RB; Jönsson-Rylander AC; Sun J; Kuan-Celarier A; Li L; Abe K; Zukowska Z; Toretsky JA; Kitlinska J
Oncogene; 2010 Oct; 29(41):5630-42. PubMed ID: 20676138
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance.
Czarnecka M; Trinh E; Lu C; Kuan-Celarier A; Galli S; Hong SH; Tilan JU; Talisman N; Izycka-Swieszewska E; Tsuei J; Yang C; Martin S; Horton M; Christian D; Everhart L; Maheswaran I; Kitlinska J
Oncogene; 2015 Jun; 34(24):3131-43. PubMed ID: 25132261
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma.
Galli S; Naranjo A; Van Ryn C; Tilan JU; Trinh E; Yang C; Tsuei J; Hong SH; Wang H; Izycka-Swieszewska E; Lee YC; Rodriguez OC; Albanese C; Kitlinska J
Am J Pathol; 2016 Nov; 186(11):3040-3053. PubMed ID: 27743558
[TBL] [Abstract][Full Text] [Related]
12. Molecular crosstalk between Y5 receptor and neuropeptide Y drives liver cancer.
Dietrich P; Wormser L; Fritz V; Seitz T; De Maria M; Schambony A; Kremer AE; Günther C; Itzel T; Thasler WE; Teufel A; Trebicka J; Hartmann A; Neurath MF; von Hörsten S; Bosserhoff AK; Hellerbrand C
J Clin Invest; 2020 May; 130(5):2509-2526. PubMed ID: 31999643
[TBL] [Abstract][Full Text] [Related]
13. Placental Neuropeptide Y ( NPY) and NPY receptors expressions and serum NPY levels in preeclampsia.
Klinjampa R; Sitticharoon C; Souvannavong-Vilivong X; Sripong C; Keadkraichaiwat I; Churintaraphan M; Chatree S; Lertbunnaphong T
Exp Biol Med (Maywood); 2019 Apr; 244(5):380-388. PubMed ID: 30760028
[TBL] [Abstract][Full Text] [Related]
14. Development of neuropeptide Y-mediated heart innervation in rats.
Masliukov PM; Moiseev K; Emanuilov AI; Anikina TA; Zverev AA; Nozdrachev AD
Neuropeptides; 2016 Feb; 55():47-54. PubMed ID: 26589184
[TBL] [Abstract][Full Text] [Related]
15. Involvement of neuropeptide Y Y1 receptor in the regulation of amphetamine-mediated appetite suppression.
Kuo DY; Chen PN; Yu CH; Kuo MH; Hsieh YS; Chu SC
Neuropharmacology; 2012 Oct; 63(5):842-50. PubMed ID: 22732442
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y Stimulates Proliferation and Migration of Vascular Smooth Muscle Cells from Pregnancy Hypertensive Rats via Y1 and Y5 Receptors.
Zhang P; Qi YX; Yao QP; Chen XH; Wang GL; Shen BR; Han Y; Gao LZ; Jiang ZL
PLoS One; 2015; 10(7):e0131124. PubMed ID: 26131716
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y and its receptors in prostate cancer: associations with cancer invasiveness and perineural spread.
Sigorski D; Wesołowski W; Gruszecka A; Gulczyński J; Zieliński P; Misiukiewicz S; Kitlińska J; Iżycka-Świeszewska E
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5803-5822. PubMed ID: 36583743
[TBL] [Abstract][Full Text] [Related]
18. Age related changes of neuropeptide Y-ergic system in the rat duodenum.
Budnik AF; Aryaeva D; Vyshnyakova P; Masliukov PM
Neuropeptides; 2020 Apr; 80():101982. PubMed ID: 31708113
[TBL] [Abstract][Full Text] [Related]
19. The mPVN mediates blockade of NPY-induced feeding by a Y5 receptor antagonist: a c-FOS analysis.
Yokosuka M; Dube MG; Kalra PS; Kalra SP
Peptides; 2001 Mar; 22(3):507-14. PubMed ID: 11287108
[TBL] [Abstract][Full Text] [Related]
20. The identification of neuropeptide Y receptor subtype involved in phenylpropanolamine-induced increase in oxidative stress and appetite suppression.
Hsieh YS; Kuo MH; Chen PN; Kuo DY
Neuromolecular Med; 2013 Mar; 15(1):159-68. PubMed ID: 23179670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]